Participate in the bio-industry's most in-depth, global study: 12th Annual Biopharmaceutical Manufacturing Report and Survey
Participate in the bio-industry's most in-depth, global study: 12th Annual Biopharmaceutical Manufacturing Report and Survey.
Your input is important as BioPlan Associates, Inc., benchmarks global and regional trends affecting our industry. You will receive a FREE summary of the results of this important global study; our 159 Key Industry Facts White Paper; AND for each completed survey BioPlan will donate $10 (up to $10,000) to global health charities. Takes between 5-25 minutes, depending on your areas of expertise.
Participate in this year’s 12th Annual Report! Be part of the bio-industry’s most authoritative, comprehensive analysis! Participants contribute to industry benchmarking, are first to receive a summary, and more!
For more information:
Donnie Elizabeth Gillespie, Project Director
BioPlan Associates, Inc.
2275 Research Blvd, Ste 500 Rockville, MD 20850 USA
Survey Methodology:The Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production by BioPlan Associates, Inc. yields a composite view and trend analysis from hundreds of responsible individuals at biopharmaceutical manufacturers and contract manufacturing organizations (CMOs) in 31 countries. The methodology also encompassed an additional 200 direct suppliers of materials, services and equipment to this industry. This survey covers such issues as: new product needs, facility budget changes, current capacity, future capacity constraints, expansions, use of disposables, trends and budgets in disposables, trends in downstream purification, quality management and control, hiring issues, and employment. The quantitative trend analysis provides details and comparisons of production by biotherapeutic developers and CMOs. It also evaluates trends over time, and assesses differences in the world's major markets in the U.S. and Europe.
Have Your Say
Rate this feature and give us your feedback in the comments section below